Traws Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Traws Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Traws Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.48M, a 78.8% decline year-over-year.
  • Traws Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18.9M, a 0.08% increase from 2022.
  • Traws Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19M, a 17.3% decline from 2021.
  • Traws Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$16.2M, a 35.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.48M -$3.74M -78.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$123M -$119M -2797% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q3 2023 -$4.74M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$4.25M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q4 2019 -$21.5M -$5.75M -$96K -1.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$21.4M -$4.6M +$753K +14.1% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$22.2M -$3.56M +$923K +20.6% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$23.1M -$7.6M -$2.51M -49.3% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
Q4 2018 -$20.6M -$5.65M +$555K +8.94% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$21.1M -$5.35M +$1.61M +23.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$22.7M -$4.48M -$1.9M -73.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$20.8M -$5.09M +$3.25M +39% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$24.1M -$6.21M -$759K -13.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$23.3M -$6.96M -$5.36M -335% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$18M -$2.58M +$2.8M +52% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$20.8M -$8.34M -$1.1M -15.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$19.7M -$5.45M -$8.64M -271% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$11M -$1.6M +$4.27M +72.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$15.3M -$5.38M +$3.57M +39.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$18.9M -$7.24M +$5.1M +41.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$24M $3.19M +$16.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$40.5M -$5.87M +$9.01M +60.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$49.5M -$8.96M +$7.8M +46.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$57.3M -$12.3M +$6.34M +33.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$63.7M -$13.4M +$1.24M +8.51% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$64.9M -$14.9M +$5.64M +27.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$70.6M -$16.8M -$4.19M -33.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$66.4M -$18.7M -$3.83M -25.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$62.5M -$14.6M -$4.35M -42.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$58.2M -$20.5M -$19.1M -1330% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-30
Q2 2013 -$39.1M -$12.6M -$5.15M -69.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-30
Q1 2013 -$34M -$14.8M -$4.05M -37.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-30
Q4 2012 -$29.9M -$10.3M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 -$1.44M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-20
Q2 2012 -$7.42M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-20
Q1 2012 -$10.8M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.